ERS’s collaborative licensing approach promotes widespread adoption of CRISPR/Cas9 technology.
Non-exclusive licenses are available to companies involved in development and commercialization of CRISPR/Cas9 technology, products, and services.
![YouTube](https://ersgenomics.com/wp-content/plugins/borlabs-cookie/assets/images/cb-no-thumbnail.png)
By loading the video, you agree to YouTube's privacy policy.
Learn more
![](https://ersgenomics.com/wp-content/uploads/2021/09/Quad-1024x757.jpg)
Licenses are available in a wide range of fields
- Pharmaceutical & Biotechnology
- CROs, CMOs & Tool Providers
- Companion Animal & Veterinary Applications
- Agriculture & Livestock applications
- Industrial & Synthetic Biology Applications